BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24 Share Price

Warrant

DE000VM7N4X7

Delayed Deutsche Boerse AG 02:03:27 27/06/2024 pm IST
0.95 EUR -8.65% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.09.24
Current month+76.27%
1 month+23.81%
Date Price Change
27/24/27 0.95 -8.65%
26/24/26 1.04 -5.45%
25/24/25 1.1 +6.80%
24/24/24 1.03 +19.77%
21/24/21 0.86 -3.37%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 02:03 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7N4X
ISINDE000VM7N4X7
Date issued 29/12/2023
Strike 125 $
Maturity 20/09/2024 (86 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.23
Lowest since issue 0.222
Spread 0.06
Spread %5.83%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus